ThinkstockGilead Sciences Inc. (NASDAQ: GILD) will report its first-quarter earnings Thursday after the markets close. Thomson Reuters has consensus estimates of $2.32 in earnings per share (EPS) on $6.92 billion in revenue. The first…
ThinkstockCelgene Corp. (NASDAQ: CELG) is scheduled to release its first-quarter financial results before the markets open Thursday. Thomson Reuters has consensus estimates of $1.06 in earnings per share (EPS) on $2.11 billion in revenue.…
ThinkstockThe trend towards generic drugs is nothing new. It does not matter if a drug has billions of dollars in annual sales or not, when they go off patent generics can enter the market.…
Merck has managed to beat its first-quarter earnings expectations, and handily at that.
Pfizer has reported better-than-expected first-quarter earnings and revenue and offered guidance.
Pharmaceutical giants Merck and Pfizer are both releasing their first quarter financial results early Tuesday.
Merrill Lynch brings another company to the forefront that it considers a buy. Ironwood Pharmaceuticals is viewed favorably by the brokerage firm, with nearly 30% upside.
Celladon announced negative results in clinical trial and shares plunged 80% Monday morning.
The short interest data are out for the April 15 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
Biogen reported disappointing first-quarter financials before the markets opened Friday.
A late day call on Thursday from Bank of America Merrill Lynch took GW Pharmaceuticals' share price target far higher.
Amgen reported better-than-expected first-quarter 2015 earnings Tuesday afternoon after equity markets had closed.
After markets close on Tuesday, Amgen, the second-largest biotech, is scheduled to announce its first-quarter results.
La Jolla Pharmaceutical has received an analyst call that implies a potential doubling of its shares.
Teva Pharmaceutical Industries has just approached Mylan with a public takeover bid valued at $82 per share in cash and stock.